Arrowhead Pharmaceuticals, Inc. (ARWR)
Company Info
| ISIN | US04280A1007 |
|---|---|
| CUSIP | 04280A100 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $2.49B |
|---|---|
| EPS | -$1.92 |
| PEG Ratio | -1.32 |
| Revenue (TTM) | $240.74M |
| Gross Profit (TTM) | $243.23M |
| EBITDA (TTM) | -$193.49M |
| Year Range | $20.67 - $42.48 |
| Target Price | $55.85 |
| Short % | 8.77% |
| Short Ratio | 7.67 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in Arrowhead Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Popular comparisons: ARWR vs. PODD, ARWR vs. QQQ, ARWR vs. XBI
Return
Arrowhead Pharmaceuticals, Inc. had a return of -42.87% year-to-date (YTD) and -27.64% in the last 12 months. Over the past 10 years, Arrowhead Pharmaceuticals, Inc. had an annualized return of 9.84%, which was very close to the S&P 500 benchmark's annualized return of 9.87%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -42.87% | 19.67% |
| 1 month | -10.16% | 8.42% |
| 6 months | -35.73% | 7.29% |
| 1 year | -27.64% | 12.71% |
| 5 years (annualized) | 9.81% | 10.75% |
| 10 years (annualized) | 9.84% | 9.87% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -2.82% | 3.63% | -3.20% | -19.93% | -2.79% | -8.49% | -13.79% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Arrowhead Pharmaceuticals, Inc. (ARWR) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ARWR Arrowhead Pharmaceuticals, Inc. | -0.45 | ||||
^GSPC S&P 500 | 0.91 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Arrowhead Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Arrowhead Pharmaceuticals, Inc. was 99.96%, occurring on Dec 16, 2016. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.96% | Dec 17, 1993 | 3824 | Dec 16, 2016 | — | — | — |
Volatility Chart
The current Arrowhead Pharmaceuticals, Inc. volatility is 37.36%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.